Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.

Innovative linkers, connecting antibodies to payloads, are fine-tuning ADC selectivity while broadening their therapeutic ...

Moderna has announced the expansion of its US manufacturing capabilities with the onshoring of drug product manufacture to ...

Novartis' two new sites in North Carolina fall under the Swiss pharma’s $23bn US manufacturing onshoring ploy.

Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...

Mesenchymal stem cells have been explored across a wide range of diseases due to their potential to reduce inflammation and ...

Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...

Roche has conditional marketing authorisation from the EC for Lunsumio SC for adults with R/R FL after at least two systemic ...

CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.